AWM
FLGT icon

Accel Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Accel Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,830
Closed -$57.1K – 405
2023
Q1 		$57.1K Hold
1,830
– – 0.02% 449
2022
Q4 		$54.5K Hold
1,830
– – 0.03% 340
2022
Q3 		$71K Hold
1,830
– – 0.04% 305
2022
Q2 		$107K Sell
1,830
-100
-5% -$5.5K 0.06% 223
2022
Q1 		$121K Sell
1,930
-70
-4% -$4.61K 0.06% 229
2021
Q4 		$201K Hold
2,000
– – 0.1% 166
2021
Q3 		$180K Hold
2,000
– – 0.12% 148
2021
Q2 		$184K Buy
+2,000
New +$160K 0.12% 163

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Accel Wealth Management's FLGT Position: Q2 2023 in Review

Accel Wealth Management sold out of Fulgent Genetics (FLGT) in Q2 2023, closing a stake of 1,830 shares — an estimated $57.1K sold.

Accel Wealth Management first reported a position in FLGT in Q2 2021 and held it in 8 quarters. The position peaked at $201K in Q4 2021. 214 funds tracked by Wall St. Rank hold FLGT as of Q2 2023.

  • Accel Wealth Management reported no remaining Fulgent Genetics position as of Q2 2023 after selling out during the quarter.
  • Accel Wealth Management sold 1,830 Fulgent Genetics shares in Q2 2023, an estimated $57.1K.
  • Accel Wealth Management first reported a position in Fulgent Genetics in Q2 2021 and held it in 8 quarters.
  • Accel Wealth Management's Fulgent Genetics position peaked at $201K in Q4 2021.
  • 214 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.